Does TRANYLCYPROMINE Cause Off label use? 22 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Off label use have been filed in association with TRANYLCYPROMINE (Tranylcypromine). This represents 5.7% of all adverse event reports for TRANYLCYPROMINE.
22
Reports of Off label use with TRANYLCYPROMINE
5.7%
of all TRANYLCYPROMINE reports
0
Deaths
13
Hospitalizations
How Dangerous Is Off label use From TRANYLCYPROMINE?
Of the 22 reports, 13 (59.1%) required hospitalization, and 1 (4.5%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRANYLCYPROMINE. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does TRANYLCYPROMINE Cause?
Hypertensive crisis (53)
Contraindicated product administered (50)
Drug interaction (44)
Depression (41)
Hypertension (39)
Headache (33)
Drug ineffective (30)
Insomnia (30)
Serotonin syndrome (30)
Dizziness (27)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TRANYLCYPROMINE Alternatives Have Lower Off label use Risk?
TRANYLCYPROMINE vs TRASTUZUMAB
TRANYLCYPROMINE vs TRASTUZUMAB-ANNS
TRANYLCYPROMINE vs TRASTUZUMAB DERUXTECAN
TRANYLCYPROMINE vs TRASTUZUMAB-DKST
TRANYLCYPROMINE vs TRASTUZUMAB-DTTB